Trial Profile
A Prospective, Multicenter, Open Enrollment Study of Human Plasma-Derived Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2014
Price :
$35
*
At a glance
- Drugs Factor XIII (Primary)
- Indications Factor XIII deficiency
- Focus Adverse reactions
- Sponsors CSL Behring
- 24 Apr 2014 New trial record